Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Laninamivir>> Market Analysis Reports
 

Market Analysis Reports of Laninamivir

Global Market Report of Laninamivir (CAS 203120-17-6)
December 2024

CAS 203120-17-6 Laninamivir Chemical Report & Database
... Report & Database definitions: Name: Laninamivir: Laninamivir; (4S,5R,6R)-5-Acetamido-4-guanidino-6-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro ... : Chemical or Reaction Intermediate The Laninamivir Report & Database gives Market Consumption ...

Global Neuraminidase Inhibitor Market Growth 2023-2029
... : Segmentation by type Zanamivir Oseltamivir Peramivir Laninamivir Segmentation by application Hospital Pharmacies Drug ...

Global Neuraminidase Inhibitors Drug Market Report 2020
... Type Segmentation Oseltamivir Zanamivir Peramivir Laninamivir Industry Segmentation Hospital Pharmacy Retail ...

Global Neuraminidase Inhibitors Drug Market Research Report 2023
... Segment by Type Oseltamivir Zanamivir Peramivir Laninamivir Segment by Application Hospital Pharmacy Retail ...

Global Neuraminidase Inhibitors Drug Market Growth (Status and Outlook) 2023-2029
... : Segmentation by type Oseltamivir Zanamivir Peramivir Laninamivir Segmentation by application Hospital Pharmacy Retail ...

Impact of COVID-19 Outbreak on Neuraminidase Inhibitor, Global Market Research Report 2020
... is segmented into Zanamivir Oseltamivir Peramivir Laninamivir Segment by Application Hospital Pharmacies Drug ...

Global Neuraminidase Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
... by Type, covers Zanamivir Oseltamivir Peramivir Laninamivir Market segment by Application can be divided ...

Global Neuraminidase Inhibitors Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028
... by Type, covers Oseltamivir Zanamivir Peramivir Laninamivir Market segment by Application, can be divided ...

Neuraminidase Inhibitors Drug Market, Global Outlook and Forecast 2022-2028
... , by Type, 2021 (%) Oseltamivir Zanamivir Peramivir Laninamivir Global Neuraminidase Inhibitors Drug Market ...

Global Neuraminidase Inhibitors Drug Market Status, Trends and COVID-19 Impact Report 2021
... Type Segmentation Oseltamivir Zanamivir Peramivir Laninamivir Application Segmentation Hospital Pharmacy Retail ...

Global Neuraminidase Inhibitor Market Research Report 2025(Status and Outlook)
... include oseltamivir, zanamivir, peramivir, and laninamivir, are primarily used for the ... Segmentation (by Type) Zanamivir Oseltamivir Peramivir Laninamivir Market Segmentation (by Application) Hospital Pharmacies ...

2023-2028 Global and Regional Neuraminidase Inhibitor Industry Status and Prospects Professional Market Research Report Standard Version
... Sankyo By Types: Zanamivir Oseltamivir Peramivir Laninamivir By Applications: Hospital Pharmacies Drug Stores ...

2023-2028 Global and Regional Neuraminidase Inhibitors Drug Industry Status and Prospects Professional Market Research Report Standard Version
... Sciences By Types: Oseltamivir Zanamivir Peramivir Laninamivir By Applications: Hospital Pharmacy Retail Pharmacy ...

Global Neuraminidase Inhibitors Drug Market Research Report 2024(Status and Outlook)
... Segmentation (by Type) Oseltamivir Zanamivir Peramivir Laninamivir Market Segmentation (by Application) Hospital Pharmacy ...

Japan Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F
... was more cost-effective compared to laninamivir, zanamivir, and peramivir, establishing it as the ...

Global Influenza Na Inhibitor Market Research Report 2025(Status and Outlook)
... ), zanamivir (Relenza), peramivir (Rapivab), and laninamivir (Inavir), are primarily used for ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact